Pharmafile Logo

#RemoteDetailing

New clinical trial search engine launches

MyClinicalTrialLocator.com follows similar service from PatientsLikeMe

Text messaging fails to change stance on flu vaccine

US study of low-income, pregnant women indicates texting ineffective in changing willingness to have flu vaccine

- PMLiVE

Merz offers $385m to trump Valeant’s bid for Obagi

Could spark bidding war for dermatology specialist

- PMLiVE

Lilly to invest extra $180m in US insulin manufacturing

Response to growing demand for insulin pens for people with diabetes

- PMLiVE

David Haslam takes over as NICE chair

Replaces Sir Michael Rawlins as body gains new social care responsibilities

- PMLiVE

Celgene promotes Karen Browne to haematology director

She takes up a new role with the company's UK and Ireland business

- PMLiVE

Opportunities in the medical devices sector in India

Growing medical tourism, a burgeoning hospital sector and increased patient affluence make India an attractive prospect for medical device companies looking for partnerships

Marketing Automation for Pharma - Sign-up for your free webinar

Marketing Automation for Pharma

With Pharma Marketers increasingly being asked to do more with fewer resources, Marketing Automation is a key area that needs to be explored. Find out how it could help you...

Blue Latitude Health

- PMLiVE

It’s a beautiful day in the neighbourhood: The importance of data

Clinical trial data is vital for clinicians practicing evidence-based medicine, but even more compelling can be real-world data gathered from local real-world patients

- PMLiVE

Quality Standards – are we making the most of them?

As the UK health service enters a new chapter, NICE begins developing best practice guidelines

- PMLiVE

Janssen’s first-in-class diabetes drug Invokana wins US approval

Will be first SGLT2 inhibitor to reach the market in the States

- PMLiVE

US MM&M Awards– last call for entries

Reminder to enter MM&M Awards honouring creativity and marketing effectiveness in healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links